Hepcidin is an endogenous protective factor for osteoporosis by reducing iron levels.

Abstract

Postmenopausal osteoporosis is a global health issue. Although a lack of estrogen is considered the major reason for postmenopausal osteoporosis, other factors might also contribute the etiology of the disease. In previous reports, we and others proposed that iron accumulation after menopause accelerates osteoporosis, and here, we genetically modified the expression of an endogenous hormone, hepcidin, to modulate iron status in a mouse model. Our results show that hepcidin levels negatively correlate with bone loss in both knockout and overexpression (with ovariectomy) murine models. In addition, iron overload enhances reactive oxygen species (ROS) activity and attenuates the functions of primary osteoblasts, while iron depletion could reverse this phenomenon through inhibiting the functions of primary osteoclasts. Therefore, our results provide more evidence of the 'iron accumulation' hypothesis, which suggests that high iron levels are risk factors for osteoporosis, and the 'Huang's hypothesis' that hepcidin is a potential drug target for the prevention of postmenopausal osteoporosis.

• Authors: Peng Zhang, Sheng Wang, Liang Wang, Bin Chen Shan, Hui Zhang, Fan Yang, Zhi Qiang Zhou, Xiao Wang, Ye Yuan, You Jia Xu
• Journal: Journal of molecular endocrinology (J Mol Endocrinol) Vol. 60 Issue 4 Pg. 297-306 (05 2018) ISSN: 1479-6813 [Electronic] England
• PMID: 29563156 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2018 Society for Endocrinology.

Chemical References

• Hepcidins
• Reactive Oxygen Species
• Iron

Topics

• Animals
• Bone Resorption (genetics, pathology)
• Cells, Cultured
• Disease Models, Animal
• Hepcidins (metabolism)
• Iron (metabolism)
• Mice, Inbred C57BL
• Mice, Knockout
• Osteoblasts (metabolism, pathology)
• Osteoclasts (metabolism)
• Osteogenesis (genetics)
• Osteoporosis (metabolism, pathology)
• Phenotype
• Reactive Oxygen Species (metabolism)